Radiation-induced coronary artery disease: prevention, screening and contemporary management Artykuł przeglądowy
##plugins.themes.bootstrap3.article.main##
Abstrakt
Radiotherapy has become an integral component of modern cancer treatment, contributing substantially
to improved survival among patients with thoracic malignancies. However, as the number
of long-term cancer survivors continues to increase, the recognition of late cardiovascular
complications has become an important aspect of survivorship care. Among these complications,
radiation-induced coronary artery disease (RICAD) represents one of the most clinically significant
manifestations of radiation-associated cardiotoxicity, contributing to considerable long-term morbidity
and mortality. The pathogenesis of RICAD is multifactorial and differs from conventional atherosclerosis,
involving radiation-induced endothelial injury, chronic inflammation, oxidative stress, and
progressive vascular fibrosis, ultimately leading to accelerated coronary artery disease. The clinical
presentation is frequently delayed by many years after completion of radiotherapy and may remain
asymptomatic or present with atypical manifestations, making timely diagnosis particularly challenging.
The risk of RICAD is influenced not only by the radiation dose delivered to the heart but also by
patient characteristics, cardiovascular comorbidities, tumour location, and advances in radiotherapy
techniques. As cancer survival continues to improve, identification of high-risk patients, implementation
of appropriate screening strategies, and selection of optimal diagnostic and therapeutic approaches
have become increasingly important in clinical practice. This review summarizes the current
evidence regarding risk factors, screening recommendations, diagnostic evaluation, contemporary
management, and preventive strategies for radiation-induced coronary artery disease.
##plugins.generic.usageStats.downloads##
##plugins.themes.bootstrap3.article.details##

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne 4.0 Międzynarodowe.
Copyright: ? Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
Bibliografia
2. Venkatesulu BP, Mahadevan LS, Aliru ML et al. Radiation-Induced Endothelial Vascular Injury: A Review of Possible Mechanisms. JACC Basic Transl Sci. 2018; 3: 563-72.
3. Cuomo JR, Javaheri SP, Sharma GK et al. How to prevent and manage radiation-induced coronary artery disease. Heart. 2018; 104: 1647-53.
4. Denham JW, Hauer-Jensen M. The radiotherapeutic injury – a complex ‘wound’. Radiother Oncol. 2002; 63: 129-45.
5. Orzan F, Brusca A, Conte MR et al. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J. 1993; 69: 496-500.
6. van Rosendael AR, Daniëls LA, Dimitriu-Leen AC et al. Different manifestation of irradiation induced coronary artery disease detected with coronary computed tomography compared with matched non-irradiated controls. Radiother Oncol. 2017; 125: 55-61.
7. van Nimwegen FA, Schaapveld M, Cutter DJ et al. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. J Clin Oncol. 2016; 34: 235-43.
8. Darby SC, Ewertz M, McGale P et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368: 987-98.
9. Frandsen J, Boothe D, Gaffney DK et al. Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol. 2015; 6: 516-23.
10. Gharzai L, Verma V, Denniston KA et al. Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database. PLoS One. 2016; 11: e0158916.
11. Ming X, Feng Y, Yang C et al. Radiation-induced heart disease in lung cancer radiotherapy. Medicine (Baltimore). 2016; 95: e5051.
12. Kirresh A, White L, Mitchell A et al. Radiation-induced coronary artery disease: a difficult clinical conundrum. Clin Med (Lond). 2022; 22: 251-6.
13. Cheng Y, Nie X, Ji C et al. Long‐Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. J Am Heart Assoc. 2017; 6: e005633.
14. Girinsky T, M’Kacher R, Lessard N et al. Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis. Int J Radiat Oncol Biol Phys. 2014; 89: 59-66.
15. Wilson J, Jun Hua C, Aziminia N et al. Imaging of the Acute and Chronic Cardiovascular Complications of Radiation Therapy. Circ Cardiovasc Imaging. 2025; 18: e017454.
16. Desai MY, Jellis CL, Kotecha R et al. Radiation-Associated Cardiac Disease: A Practical Approach to Diagnosis and Management. JACC Cardiovasc Imaging. 2018; 11: 1132-49.
17. Huang Y-J, Lin J-A, Chen W-M et al. Statin Therapy Reduces Radiation-Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy. J Am Heart Assoc. 2024; 13: e036411.
18. Vrints C, Andreotti F, Koskinas KC et al. 2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024; 45: 3415-537.
19. Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011; 2011: 317659.
20. Veeragandham RS, Goldin MD. Surgical management of radiation-induced heart disease. Ann Thorac Surg. 1998; 65: 1014-9.
21. Lancellotti P, Nkomo VT, Badano LP et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013; 14: 721-40.
22. Mulliez T, Veldeman L, Speleers B et al. Heart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation. Radiother Oncol. 2015; 114: 79-84.
23. Bergom C, Bradley JA, Ng AK et al. Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification. JACC CardioOncol. 2021; 3: 343-59.